[ARCHITECT Chagas(®): a new diagnostic tool in Chagas disease]. / ARCHITECT Chagas(®): una nueva herramienta diagnóstica en la enfermedad de Chagas.
Enferm Infecc Microbiol Clin
; 30(8): 463-5, 2012 Oct.
Article
em Es
| MEDLINE
| ID: mdl-22446008
ABSTRACT
OBJECTIVE:
To evaluate a new chemiluminescent microparticle immunoassay (ARCHITECT Chagas(®), Abbott).METHODS:
In this study, 165 samples were tested by two different serological tests. The ARCHITECT Chagas(®) assay was performed using ARCHITECT i2000(SR) system (Abbott).RESULTS:
The sensitivity and specificity of ARCHITECT assay was 100% and 96.6%, respectively. The concordance rate was 0.96 (95%CI 0.92-1) for ELISA and 0.91 (95%CI 0.85-0.97) for immunofluorescence assay (IFA).CONCLUSIONS:
The ARCHITECT Chagas(®) assay demonstrates a sensitivity and specificity similar to ELISA and IFA assays; it allows a large volume of samples to be processed with a good standardization and reproducibility, as well as an objective interpretation.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Tipo de estudo:
Diagnostic_studies
Limite:
Humans
Idioma:
Es
Ano de publicação:
2012
Tipo de documento:
Article